•Talon Metals acquired Eagle Mine and Humboldt Mill, transforming from a speculative nickel developer to an operational entity with cash flow and infrastructure.
•Recent technical reports support Eagle's operational life through 2030, while high-grade Vault Zone drill results enhance Tamarack project development potential.
•Oil is set for the largest quarterly price drop in 6 years as workarounds for the Strait of Hormuz chokepoint and a drop in crude imports to China ease the historic supply crunch.
•BMO Financial Group announced a definitive agreement to acquire the Australia-based capital markets business of Euroz Hartleys Group Limited (ASX:EZL).
•German inflation fell in June to its lowest level since the start of the Middle East war, showing few signs of knock-on effects from higher energy prices.
•Lobbying efforts to kill a proposed ban on some defense contractors buying back their own stock in the National Defense Authorization Act for fiscal 2027 are heating up.
•British American Tobacco plans to cut 5,500 jobs and outsource 3,500 roles as part of an AI-driven restructuring amid declining traditional tobacco sales.
•The U.S. Department of Justice filed a lawsuit against United Parks & Resorts Inc. (UPR) for a policy banning guests with disabilities from using wheeled walkers with seats.
•Copart announced a leadership change effective July 31, 2026; CEO Jeff Liaw steps down and Executive Chairman and former CEO Jay Adair returns as CEO.
•OpenPayd announced the filing of a registration statement on Form F-4 with the SEC in connection with its proposed business combination with Titan Acquisition Corp. (TACH).
•The combined company is expected to become a Nasdaq-listed public company under the ticker 'OP' with an implied pro forma equity value exceeding $1 billion.
•Up to approximately $276 million in gross proceeds are available from Titan's trust account, assuming no redemptions by Titan's public shareholders.
•Australia's competition regulator has taken Amazon's Australian unit to court, alleging its Prime subscription contracts contained unfair terms that allowed advertising to be added to Prime Video.
•Novocure (NASDAQ: NVCR) announced that Optune Pax has received CE Mark for the treatment of adult patients with locally advanced pancreatic cancer of exocrine origin, concomitant with gemcitabine and nab-paclitaxel.
